Performance
Tesamorelin
30 MG
Studied for:
- Visceral Fat Reduction
- Muscle Support
- Lean Body Composition
$449 $224 50% off
Clinician reviewed · Full refund if not prescribed
Black Friday offer50% off your first month
Performance peptides
Recovery peptides
Beauty peptides

Performance
Tesamorelin
A growth-hormone-releasing peptide designed to support visceral fat reduction, lean body composition, and metabolic health.
$449 $224 50% off
$359/mo thereafter

Performance
CJC + Ipamorelin
A growth-hormone-targeting peptide combination designed to support muscle development, body composition, sleep, and recovery.
$379 $189 50% off
$303/mo thereafter

Performance
MOTS-c
A mitochondrial-derived peptide being studied for its potential role in metabolism, cellular energy, endurance, and insulin sensitivity.
$449 $224 50% off
$359/mo thereafter

Recovery · Stack
Wolverine
A combination of BPC-157 and TB-500 designed to support advanced tissue repair, injury recovery, and a healthy inflammatory response.
$379 $189 50% off
$303/mo thereafter

Recovery · Stack
KLOW
A four-peptide blend of BPC-157, TB-500, GHK-Cu, and KPV designed to support advanced skin renewal, tissue repair, recovery, and healthy aging.
$449 $224 50% off
$359/mo thereafter

Recovery
BPC-157
A recovery-focused peptide designed to support the body's natural tissue repair, gut health, and inflammatory response.
$299 $149 50% off
$239/mo thereafter

Beauty · Stack
GLOW
A three-peptide blend of BPC-157, TB-500, and GHK-Cu designed to support skin renewal, collagen production, tissue repair, and recovery.
$379 $189 50% off
$303/mo thereafter

Beauty
GHK-Cu
A naturally occurring copper peptide studied for its role in collagen production, skin renewal, and healthy aging.
$299 $149 50% off
$239/mo thereafter
Black Friday50% OFFFirst month







KLOW
BPC-157 10 MG · TB-500 10 MG · GHK-Cu 50 MG · KPV 10 MG
KLOW builds on GLOW (BPC-157, TB-500, GHK-Cu) and adds KPV, an anti-inflammatory tripeptide.
Studied for:
Add to cartFull refund if your prescription isn't approved

What KLOW may support
Studied for, not promised. Your clinician helps you decide what’s right for you.
Skin renewal
Firmer, more elastic skin with fewer fine lines (GHK-Cu), and less redness (KPV).
Tissue repair
Faster soft-tissue and tendon repair (BPC-157, TB-500) and wound healing (GHK-Cu, KPV).
Inflammatory response
Lower pro-inflammatory cytokines (IL-6, TNF-α, IL-1β) across three of the four peptides.
Gut health
Protection of the gastric mucosa (BPC-157) and mucosal healing in models of colitis (KPV).
Real results
“I switched to KLOW after a minor injury when my recovery felt like it was stalling out. My joints definitely feel less stiff when I wake up, and I actually have a spring in my step again. It’s been a staple in my routine since.”
“I was just dragging through the afternoons at work a bit. Adding MOTS-C gave me very steady clean energy and an extra dose of motivation. I’m finally pushing past plateaus and feel like I have way more energy.”
“The very first thing I noticed with the CJC-1295 and Ipamorelin combo was how much better my workouts were. I started leaning out and retaining muscle much easier without changing my diet. I’ve been a loyal Peppi customer ever since.”
“I started Wolverine because I had a few nagging things that just weren’t getting better. It wasn’t some overnight change, but after a few weeks I felt less beat up and could train more consistently again. The pen was also way easier than I expected.”
“I tried Glow to improv my skin, and after a few weeks it definitely looked more hydrated and less wrinkly. I also felt like I bounced back a little better after workouts. I’m a big fan of the product.”
“I had been doing the right things but still wasn’t seeing much change around my waist. My friend recommended Tesamorelin from Peppi and I noticed my clothes started fitting better and I could actually see the progress. Having a clinician check in made it feel a lot more legit than things I’d tried before.”
“I tried BPC-157 during a frustrating stretch where recovery after workouts was taking forever. I started waking up less sore and then I slowly got more comfortable training again. It was simple to use and didn’t take over my whole routine.”
“I originally got GHK-Cu for some lingering skin texture issues. It took a month or two, but my face feels significantly plumper and the fine lines look softer. A surprise bonus was that my hair actually started feeling a lot thicker at the roots, too.”
Results come in stages. Here's the first six months.
Week 1Build the routine
Start consistently and track the issues you want to improve, including comfort, movement, and workout recovery. Keep following the rest of your recovery plan.
Weeks 2–4Feel early signals
Everyday movement may begin to feel easier, with less soreness after normal activity.
Months 2–3Experience consistent relief
Relief may feel more dependable from one day to the next. Movement, rehab work, and controlled training should start feeling easier to repeat consistently.
Months 4–6Sustain the benefit
The goal is steady function with fewer setbacks and more confidence in your routine.

For best resultsPeptide therapy is cumulative. We recommend patients commit 4-6 months for results to build.

*Applies only if a practitioner prescribes treatment. Onset and response vary by individual; statements pending medical review and are not a guarantee of outcomes.
BPC-157 10 mg + TB-500 10 mg + GHK-Cu 50 mg + KPV 10 mg
KLOW builds on GLOW (BPC-157, TB-500, GHK-Cu) and adds KPV, an anti-inflammatory tripeptide: four peptides in one pen for skin renewal, tissue repair and the inflammatory response.
A 15-amino-acid peptide first described in 1993 and isolated from human gastric juice. It protects the lining of blood vessels and promotes new ones.
An acetylated seven-amino-acid fragment (Ac-LKKTETQ) from the active site of thymosin β4. Its functions include actin binding, wound healing, angiogenesis and skin repair.
A naturally occurring copper tripeptide in human plasma, discovered in 1973. It raises SOD antioxidant activity and lowers TNF-α and IL-6.
A tripeptide (Lys-Pro-Val) from the tail of α-MSH with anti-inflammatory properties: it dials down NF-κB and MAPK signaling.
What the studies show
3 of 4
Chart review · n=16patients given BPC-157 together with thymosin β4 (TB-500's parent peptide) had significant knee-pain improvement.
Intra-Articular Injection of BPC 157 for Multiple Types of Knee PainAltern Ther Health Med · Jul 2021Less colitis
Preclinical · miceKPV, taken up through the PepT1 transporter, reduced DSS- and TNBS-induced colitis, with lower pro-inflammatory cytokine expression.
PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal InflammationGastroenterology · Jan 2008TB-500 and KPV on their own: no published human trials yet; their data is preclinical.
Prescription required. Your clinician determines whether it's appropriate for you. For educational purposes only, not medical advice. Summarized from published research; studies listed by PubMed ID.
Lot KL91726: 4 of 4 tests passed.
Every batch passes four independent tests before it ships to your home. This lot was published Oct 12, 2026.
PotencyPassed
99.83%
Blend purity · specification >98%
Labeled 80 mg total · measured 81.23 mg total · identity confirmed
SterilityPassed
Not detected
Rapid screen for microbial contamination.
Rapid sterility screening (qPCR)
pHPassed
6.6
Within the 4.5–7.0 reference range for a comfortable injection.
Reference range 4.5–7.0
EndotoxicityPassed
<2.5 EU/mL
Acceptance limit ≤5.0 EU/mL for injectables.
LAL assay
| Peptide | Measured | Purity |
|---|---|---|
| KPV | 11.126 mg | 99.84% |
| GHK-Cu | 49.036 mg | 99.846% |
| BPC-157 | 9.827 mg | 99.757% |
| TB-500 (17–23 fragment) | 11.226 mg | 99.817% |
| Total | 81.23 mg total | 99.83% |
From quiz to your door in 2–3 days
Step 1 Today
Step 2 Within 24 hours
Step 3 Within 2–3 days
Step 4 Every 28 days
How Peppi compares
| Peppi | Research-use-only peptides | |
|---|---|---|
| For human use | Yes | No |
| Pre-filled & pre-mixed | Yes | No |
| Easy dosing | Yes | No |
| Prescribed by a clinician | Yes | No |
| Dispensed from a pharmacy | Yes | No |
| Third-party lab tested | Yes | No |
| Ongoing care team | Yes | No |
Not sure where to start?
Answer a few questions and we'll tell you where to start.
Frequently asked questions
Yes, and it's built into your order. Add your peptide to the cart and check out, then answer a short medical intake. A clinician licensed in your state reviews it before anything ships. No appointment, and no separate visit. Reorders skip the intake. If your prescription isn't approved, you get a 100% refund.
KLOW is a four-peptide blend of BPC-157, TB-500, GHK-Cu and KPV, sold by Peppi as the KLOW Stack in a pre-filled prescription pen. In effect it is GLOW plus a fourth peptide, KPV. It is meant to support skin renewal, tissue repair and healthy aging, though the blend has not been studied in humans.
KLOW contains four peptides: 10 mg of BPC-157, 10 mg of TB-500, 50 mg of GHK-Cu and 10 mg of KPV in each one-month Peppi pen. BPC-157 and TB-500 are studied for tissue repair, GHK-Cu for collagen and skin renewal, and KPV for inflammation. Most of that research comes from animals or cells.
The KLOW peptide combines four peptides with separate research trails. BPC-157 and TB-500 aided tissue repair in preclinical studies, GHK-Cu boosted collagen in skin cell studies and small cream trials, and KPV eased gut inflammation in mice. How the four act together in people has not been studied, so human effects remain unproven.
KPV is a three-amino-acid peptide (lysine, proline and valine) from the tail end of alpha-melanocyte-stimulating hormone, and it is the ingredient that sets KLOW apart from GLOW. Mouse and cell studies link it to lower gut inflammation. An FDA compounding page updated in April 2026 says the agency found no human exposure data for KPV.
KLOW has no established human dosage, because no clinical trial has tested the blend. Each one-month pen holds 10 mg of BPC-157, 10 mg of TB-500, 50 mg of GHK-Cu and 10 mg of KPV. A licensed Peppi clinician sets each patient's dose, and the pen's twist-to-dose selector delivers that amount.
KLOW's timeline has not been measured in clinical trials, so any estimate comes from the maker's own guidance. Peppi calls peptide therapy cumulative and recommends committing 4 to 6 months, and its KLOW page says early signals may appear in weeks 2 to 4. Response varies from person to person and is not guaranteed.
This may vary depending upon a number of factors, but you are required to meet with your prescribing clinician at least once every three months. If you would like to meet with them more frequently, you are certainly able to.
Have more questions?
Email: [email protected]
Call: +1 302-499-3831
Important safety information
KLOW is not an FDA-approved drug, and the blend has not been studied in people. FDA has identified no human exposure data for KPV or TB-500, and human data on injectable GHK-Cu are limited. KLOW is not approved to treat any condition. Treatment carries risks and may not be appropriate for everyone, and BPC-157 and TB-500 are prohibited in tested sport.
Peppi's KLOW pen is prepared by a licensed U.S. 503A compounding pharmacy. No trial has tested the KLOW blend itself in people.
Prescription treatment is subject to independent medical evaluation and applicable legal requirements. A consultation does not guarantee a prescription, and nothing on this page is a guarantee of results.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
More peptide pens from Peppi.
Performance
30 MG
Studied for:
$449 $224 50% off
Clinician reviewed · Full refund if not prescribed
Performance
40 MG
Studied for:
$449 $224 50% off
Clinician reviewed · Full refund if not prescribed
Recovery
BPC-157 + TB-500
Studied for:
$379 $189 50% off
Clinician reviewed · Full refund if not prescribed
Recovery
10 MG
Studied for:
$299 $149 50% off
Clinician reviewed · Full refund if not prescribed